|
Index of reports
> Cases resulting in disability (2)
> Cases with Gastrooesophageal Reflux Disease (2)
Below is the selection of adverse event reports related to Creon (Amylase / Lipase / Protease) that includes cases resulting in disability where reactions include gastrooesophageal reflux disease.
Adverse event in 811 month old male receiving Creon (Amylase / Lipase / Protease)
Reported by a physician from Germany on 2007-04-03
Patient: 811 month old male, weighing 74.0 kg (162.8 pounds)
Adverse reactions / side effects: Pancreatic Insufficiency, Gastrooesophageal Reflux Disease, Abdominal Pain Upper, Hepatic Enzyme Increased
Adverse event resulted in: disablity
Suspect drug(s):
Creon
Dosage: daily dose: 1 capsule
Indication: Pancreatic Insufficiency
Start date: 2006-01-01
Creon
Dosage: daily dose: 3 dosage form
Start date: 2006-01-01
Creon
Dosage: daily dose: 9 dosage form
Start date: 2006-01-01
Adverse event in 811 month old male receiving Creon (Amylase / Lipase / Protease)
Reported by a consumer/non-health professional from Germany on 2007-03-07
Patient: 811 month old male, weighing 74.0 kg (162.8 pounds)
Adverse reactions / side effects: Gastrooesophageal Reflux Disease, Hepatic Enzyme Increased, Abdominal Pain Upper
Adverse event resulted in: disablity
Suspect drug(s):
Creon
Dosage: daily dose: 1 capsule
Indication: Pancreatic Insufficiency
Start date: 2006-01-01
Creon
Dosage: daily dose: 3 dosage form
Start date: 2006-01-01
Creon
Dosage: daily dose: 9 dosage form
Start date: 2006-01-01
|
